Last reviewed · How we verify
Chlamydial conjunctivitis
Approved treatments
- Klaron · Merck & Co.
- Azo Gantanol · Pfizer
- Azo Gantrisin · Alra
- E-Mycin · Generic (originally Abbott/Lilly)
- Benzamycin · Pfizer
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Chlamydial conjunctivitis patent landscape — cliff calendar, originator estates, attackable patents
- Chlamydial conjunctivitis treatment landscape brief
- Chlamydial conjunctivitis treatment updates RSS
Frequently asked questions about Chlamydial conjunctivitis
What drugs treat Chlamydial conjunctivitis?
Tracked treatments include Klaron, Azo Gantanol, Azo Gantrisin, E-Mycin, Benzamycin.
What is the treatment for Chlamydial conjunctivitis?
Standard treatment for Chlamydial conjunctivitis includes Klaron, Azo Gantanol, Azo Gantrisin, E-Mycin, Benzamycin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Chlamydial conjunctivitis patent cliff · Chlamydial conjunctivitis CI report
- Treatment: Klaron · Merck & Co.
- Treatment: Azo Gantanol · Pfizer
- Treatment: Azo Gantrisin · Alra
- Treatment: E-Mycin · Generic (originally Abbott/Lilly)
- Treatment: Benzamycin · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing